{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:30:32Z","timestamp":1788240632170,"version":"build-2803163510"},"reference-count":74,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Background\/Objectives: Multiple system atrophy (MSA) presents a challenging diagnosis due to its clinical overlap with other neurodegenerative disorders, especially other \u03b1-synucleinopathies. The main purpose of this systematic review and meta-analysis was to assess neurofilament light chain (NfL) differences in the CSF and blood of patients with MSA versus the healthy control group (HC), patients with Parkinson\u2019s disease (PD) and patients with Lewy body dementia (LBD). Secondarily, the diagnostic metrics of CSF and circulating NfL in MSA versus HC, PD, LBD, progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) were discussed. Methods: MEDLINE and EMBASE were thoroughly searched for relevant case-control studies. Standardized mean differences (SMDs) were calculated separately for CSF and blood NfL per comparison. Statistical heterogeneity was assessed based on the Q and I^2 statistics. Results: Twenty-five relevant studies were retrieved. Quantitative syntheses revealed elevated CSF and circulating NfL levels in individuals with MSA versus HC [SMD = 1.80 (95%CI = 1.66, 1.94) and SMD = 2.00 (95%CI = 1.36, 2.63), respectively] versus PD [SMD = 1.65 (95%CI = 1.26, 2.03) and SMD = 1.63 (95%CI = 0.84, 2.43), respectively] as well as versus LBD [SMD = 1.17, (95%CI = 0.71, 1.63) and SMD = 0.65 (95%CI = 0.30, 1.00), respectively]. Diagnostic accuracy was outstanding for CSF and blood NfL in MSA versus HC and PD, and it was moderate in MSA versus LBD. On the other hand, it was suboptimal in MSA vs. PSP and CBD. Conclusions: Both CSF and circulating NfL levels are elevated in MSA compared to HC, PD and LBD. To achieve optimal diagnostic properties, further work is required in the standardization of processes and the establishment of reference NfL intervals and\/or thresholds.<\/jats:p>","DOI":"10.3390\/brainsci15030241","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T06:13:18Z","timestamp":1740463998000},"page":"241","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Neurofilament Light Chain in Cerebrospinal Fluid and Blood in Multiple System Atrophy: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5105-0196","authenticated-orcid":false,"given":"Silvia","family":"Demiri","sequence":"first","affiliation":[{"name":"Department of Neurology, University Hospital of Patras, School of Medicine, University of Patras, 26504 Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra","family":"Veltsista","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital of Patras, School of Medicine, University of Patras, 26504 Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Siokas","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital of Larissa, School of Medicine, University of Thessaly, 41100 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanellos C.","family":"Spiliopoulos","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital of Patras, School of Medicine, University of Patras, 26504 Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Tsika","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital of Larissa, School of Medicine, University of Thessaly, 41100 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polyxeni","family":"Stamati","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital of Larissa, School of Medicine, University of Thessaly, 41100 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Chroni","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital of Patras, School of Medicine, University of Patras, 26504 Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2957-641X","authenticated-orcid":false,"given":"Efthimios","family":"Dardiotis","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital of Larissa, School of Medicine, University of Thessaly, 41100 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2958-5220","authenticated-orcid":false,"given":"Ioannis","family":"Liampas","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital of Patras, School of Medicine, University of Patras, 26504 Patras, Greece"},{"name":"Department of Neurology, University Hospital of Larissa, School of Medicine, University of Thessaly, 41100 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/pn-2020-002797","article-title":"Multiple system atrophy","volume":"23","author":"Goh","year":"2023","journal-title":"Pract. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S1474-4422(15)00058-7","article-title":"Natural history of multiple system atrophy in the USA: A prospective cohort study","volume":"14","author":"Low","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMra1311488","article-title":"Multiple-System Atrophy","volume":"372","author":"Fanciulli","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.autneu.2017.10.007","article-title":"Diagnosis of multiple system atrophy","volume":"211","author":"Palma","year":"2018","journal-title":"Auton. Neurosci. Basic Clin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40035-023-00370-0","article-title":"Multidimensional biomarkers for multiple system atrophy: An update and future directions","volume":"12","author":"Wan","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"117229","DOI":"10.1016\/j.jns.2020.117229","article-title":"The relationship between neurofilament light chain and cognition in neurological disorders: A scoping review","volume":"420","author":"Ramani","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"van Zeggeren, I.E., Ter Horst, L., Heijst, H., Teunissen, C.E., van de Beek, D., and Brouwer, M.C. (2022). Neurofilament light chain in central nervous system infections: A prospective study of diagnostic accuracy. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-17643-9"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Liampas, I., Kyriakoulopoulou, P., Karakoida, V., Kavvoura, P.A., Sgantzos, M., Bogdanos, D.P., Stamati, P., Dardiotis, E., and Siokas, V. (2024). Blood-Based Biomarkers in Frontotemporal Dementia: A Narrative Review. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252111838"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Gallingani, C., Carbone, C., Tondelli, M., and Zamboni, G. (2024). Neurofilaments Light Chain in Neurodegenerative Dementias: A Review of Imaging Correlates. Brain Sci., 14.","DOI":"10.3390\/brainsci14030272"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10286-014-0265-7","article-title":"A short clinical history of multiple system atrophy","volume":"25","author":"Quinn","year":"2015","journal-title":"Clin. Auton. Res. Off. J. Clin. Auton. Res. Soc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00702-021-02419-8","article-title":"A historical review of multiple system atrophy with a critical appraisal of cellular and animal models","volume":"128","author":"Marmion","year":"2021","journal-title":"J. Neural Transm."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-510X(89)90219-0","article-title":"Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome)","volume":"94","author":"Papp","year":"1989","journal-title":"J. Neurol. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.tins.2011.08.003","article-title":"Multiple System Atrophy: A Clinical and Neuropathological Perspective","volume":"34","author":"Ubhi","year":"2011","journal-title":"Trends Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Valera, E., Spencer, B., Mott, J., Trejo, M., Adame, A., Mante, M., Rockenstein, E., Troncoso, J.C., Beach, T.G., and Masliah, E. (2017). MicroRNA-101 Modulates Autophagy and Oligodendroglial Alpha-Synuclein Accumulation in Multiple System Atrophy. Front. Mol. Neurosci., 10.","DOI":"10.3389\/fnmol.2017.00329"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Le\u0144ska-Mieciek, M., Madetko-Alster, N., Alster, P., Kr\u00f3licki, L., Fiszer, U., and Koziorowski, D. (2023). Inflammation in multiple system atrophy. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1214677"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00702-021-02383-3","article-title":"Neuropathology of multiple system atrophy: Kurt Jellinger`s legacy","volume":"128","author":"Campese","year":"2021","journal-title":"J. Neural Transm."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10286-017-0500-0","article-title":"First symptoms in multiple system atrophy","volume":"28","author":"McKay","year":"2018","journal-title":"Clin. Auton. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.parkreldis.2022.02.003","article-title":"Pre-diagnostic presentations of Multiple System Atrophy case control study in a primary care dataset","volume":"99","author":"Schrag","year":"2022","journal-title":"Park. Relat. Disord."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/archneur.64.2.256","article-title":"Early development of autonomic dysfunction may predict poor prognosis in patients with multiple system atrophy","volume":"64","author":"Tada","year":"2007","journal-title":"Arch. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00702-013-1133-7","article-title":"Cerebellar and parkinsonian phenotypes in multiple system atrophy: Similarities, differences and survival","volume":"121","author":"Roncevic","year":"2014","journal-title":"J. Neural Transm."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1212\/WNL.0000000000001807","article-title":"When DLB, PD, and PSP masquerade as MSA: An autopsy study of 134 patients","volume":"85","author":"Koga","year":"2015","journal-title":"Neurology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neurobiolaging.2020.07.018","article-title":"Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer\u2019s disease","volume":"95","author":"Andersson","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Freedman, M.S., Gnanapavan, S., Booth, R.A., Calabresi, P.A., Khalil, M., Kuhle, J., Lycke, J., and Olsson, T. (2024). Consortium of Multiple Sclerosis Centers. Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management. eBioMedicine, 101.","DOI":"10.1016\/j.ebiom.2024.104970"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1038\/s41380-024-02524-6","article-title":"Introducing neurofilament light chain measure in psychiatry: Current evidence, opportunities, and pitfalls","volume":"29","author":"Bavato","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Hozo, S.P., Djulbegovic, B., and Hozo, I. (2005). Estimating the mean and variance from the median, range, and the size of a sample. BMC Med. Res. Methodol., 5.","DOI":"10.1186\/1471-2288-5-13"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Wan, X., Wang, W., Liu, J., and Tong, T. (2014). Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med. Res. Methodol., 14.","DOI":"10.1186\/1471-2288-14-135"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.13105\/wjma.v3.i5.215","article-title":"How to impute study-specific standard deviations in meta-analyses of skewed continuous endpoints?","volume":"3","author":"Rin","year":"2015","journal-title":"World J. Meta-Anal."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/mds.870130116","article-title":"Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson\u2019s disease","volume":"13","author":"Holmberg","year":"1998","journal-title":"Mov. Disord."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Hall, S., Janelidze, S., Surova, Y., Widner, H., Zetterberg, H., and Hansson, O. (2018). Cerebrospinal fluid concentrations of inflammatory markers in Parkinson\u2019s disease and atypical parkinsonian disorders. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-31517-z"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archneurol.2012.1654","article-title":"Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and\/or Parkinsonian Disorders","volume":"69","author":"Hall","year":"2012","journal-title":"Arch. Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1353-8020(00)00083-3","article-title":"CSF-neurofilament and levodopa tests combined with discriminant analysis may contribute to the differential diagnosis of Parkinsonian syndromes","volume":"8","author":"Holmberg","year":"2001","journal-title":"Park. Relat. Disord."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jamaneurol.2015.1449","article-title":"Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease","volume":"72","author":"Linder","year":"2015","journal-title":"JAMA Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","article-title":"Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder","volume":"88","author":"Hansson","year":"2017","journal-title":"Neurology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"119975","DOI":"10.1016\/j.cca.2024.119975","article-title":"Diagnostic value of six plasma biomarkers in progressive supranuclear palsy, multiple system atrophy, and Parkinson\u2019s disease","volume":"565","author":"Chen","year":"2025","journal-title":"Clin. Chim. Acta"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00415-024-12784-5","article-title":"Serum neurofilament light chain as a diagnostic and prognostic biomarker in multiple system atrophy: A prospective cohort study","volume":"272","author":"Liu","year":"2024","journal-title":"J. Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1007\/s00415-023-11741-y","article-title":"Diagnostic and prognostic performance of plasma neurofilament light chain in multiple system atrophy: A cross-sectional and longitudinal study","volume":"270","author":"Peng","year":"2023","journal-title":"J. Neurol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Li, Q., Li, Z., Han, X., Shen, X., Wang, F., Bai, L., Li, Z., Zhang, R., Wang, Y., and Zhu, X. (2022). A Panel of Plasma Biomarkers for Differential Diagnosis of Parkinsonian Syndromes. Front. Neurosci., 16.","DOI":"10.3389\/fnins.2022.805953"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41531-023-00481-5","article-title":"Head-to-head comparison of 6 plasma biomarkers in early multiple system atrophy","volume":"9","author":"Guo","year":"2023","journal-title":"NPJ Park. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.neurobiolaging.2006.03.010","article-title":"CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson\u2019s disease","volume":"28","author":"Abdo","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e1479","DOI":"10.1212\/WNL.0000000000007179","article-title":"Serum NFL Discriminates Parkinson Disease from Atypical Parkinsonisms","volume":"92","author":"Marques","year":"2019","journal-title":"Neurology"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Herbert, M.K., Aerts, M.B., Beenes, M., Norgren, N., Esselink, R.A.J., Bloem, B.R., Kuiperij, H.B., and Verbeek, M.M. (2015). CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders. Front. Neurol., 6.","DOI":"10.3389\/fneur.2015.00091"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.1007\/s00415-024-12647-z","article-title":"GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA)","volume":"271","author":"Katzdobler","year":"2024","journal-title":"J. Neurol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1002\/mds.28738","article-title":"Systematic Assessment of 10 Biomarker Candidates Focusing on \u03b1-Synuclein-Related Disorders","volume":"36","author":"Schulz","year":"2021","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1093\/brain\/awac253","article-title":"Neurofilament light levels predict clinical progression and death in multiple system atrophy","volume":"145","author":"Chelban","year":"2022","journal-title":"Brain"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/jnnp-2014-309562","article-title":"A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes","volume":"86","author":"Magdalinou","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41531-021-00232-4","article-title":"Neurofilament light chain and \u03b1-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes","volume":"7","author":"Quadalti","year":"2021","journal-title":"NPJ Park. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.parkreldis.2011.08.012","article-title":"Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes","volume":"18","author":"Bech","year":"2012","journal-title":"Park. Relat. Disord."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.parkreldis.2022.07.007","article-title":"Clinical correlations of cerebrospinal fluid biomarkers including neuron-glia 2 and neurofilament light chain in patients with multiple system atrophy","volume":"102","author":"Tokutake","year":"2022","journal-title":"Park. Relat. Disord."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e1104","DOI":"10.1212\/WNL.0000000000008088","article-title":"Blood NfL: A biomarker for disease severity and progression in Parkinson disease","volume":"93","author":"Lin","year":"2019","journal-title":"Neurology"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Canaslan, S., Schmitz, M., Villar-Piqu\u00e9, A., Maass, F., Gmitterov\u00e1, K., Varges, D., Lingor, P., Llorens, F., Hermann, P., and Zerr, I. (2021). Detection of cerebrospinal fluid neurofilament light chain as a marker for alpha-synucleinopathies. Front. Aging Neurosci., 13.","DOI":"10.3389\/fnagi.2021.717930"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ana.25824","article-title":"Alpha-Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies","volume":"88","author":"Singer","year":"2020","journal-title":"Ann. Neurol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.parkreldis.2009.07.007","article-title":"Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson\u2019s disease and atypical parkinsonian disorders","volume":"16","author":"Constantinescu","year":"2010","journal-title":"Park. Relat. Disord."},{"key":"ref_55","first-page":"407","article-title":"Cerebrospinal fluid levels of neurofilament light chain in multiple system atrophy relative to Parkinson\u2019s disease: A meta-analysis","volume":"38","author":"Hu","year":"2017","journal-title":"Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S1474-4422(24)00396-X","article-title":"Multiple system atrophy: Advances in pathophysiology, diagnosis, and treatment","volume":"23","author":"Krismer","year":"2024","journal-title":"Lancet Neurol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e867","DOI":"10.1212\/CPJ.0000000000001116","article-title":"CSF and circulating NfL as biomarkers for the discrimination of Parkinson disease from atypical parkinsonian syndromes: Meta-analysis","volume":"11","author":"Angelopoulou","year":"2021","journal-title":"Neurol. Clin. Pract."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1080\/21678421.2021.2007952","article-title":"Neurofilament light chain as a biological marker for amyotrophic lateral sclerosis: A meta-analysis study","volume":"23","author":"Sferruzza","year":"2022","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_59","first-page":"1308","article-title":"Neurofilament light chain as a biomarker for diagnosis of multiple sclerosis","volume":"20","author":"Kouchaki","year":"2021","journal-title":"EXCLI J."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Nguyen, A.D., Malmstrom, T.K., Aggarwal, G., Miller, D.K., Vellas, B., and Morley, J.E. (2022). Serum neurofilament light levels are predictive of all-cause mortality in late middle-aged individuals. eBioMedicine, 82.","DOI":"10.1016\/j.ebiom.2022.104146"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3233\/JAD-190615","article-title":"Neurofilament light chain in cerebrospinal fluid and blood as a biomarker for neurodegenerative diseases: A systematic review and meta-analysis","volume":"72","author":"Wang","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Liampas, I., Kyriakoulopoulou, P., Siokas, V., Tsiamaki, E., Stamati, P., Kefalopoulou, Z., Chroni, E., and Dardiotis, E. (2024). Apolipoprotein E gene in \u03b1-synucleinopathies: A narrative review. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031795"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/mds.23506","article-title":"Rapidly progressive diffuse Lewy body disease","volume":"26","author":"Gaig","year":"2011","journal-title":"Mov. Disord."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00234-012-1009-9","article-title":"Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson\u2019s disease: Evaluation by 3.0-T MR imaging","volume":"54","author":"Tsukamoto","year":"2012","journal-title":"Neuroradiology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.nbd.2015.05.004","article-title":"Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative","volume":"80","author":"Laurens","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40035-023-00346-0","article-title":"Toward a biomarker panel measured in CNS-originating extracellular vesicles for improved differential diagnosis of Parkinson\u2019s disease and multiple system atrophy","volume":"12","author":"Taha","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"ref_67","first-page":"e67896","article-title":"Imaging Markers of Multiple System Atrophy and Their Association With Disease Severity: A Cross-Sectional Study","volume":"16","author":"Dash","year":"2024","journal-title":"Cureus"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/mdc3.12404","article-title":"Role of Magnetic Resonance Imaging in the Diagnosis of Multiple System Atrophy","volume":"4","author":"Kim","year":"2016","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00702-005-0382-5","article-title":"Brain SPECT imaging in multiple system atrophy","volume":"112","author":"Cilia","year":"2005","journal-title":"J. Neural Transm."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e01827","DOI":"10.1002\/brb3.1827","article-title":"Clinical features, MRI, and 18F-FDG-PET in differential diagnosis of Parkinson disease from multiple system atrophy","volume":"10","author":"Zhao","year":"2020","journal-title":"Brain Behav."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1017\/S1041610224000607","article-title":"Neuropsychiatric symptoms and white matter hyperintensities in older adults without dementia","volume":"36","author":"Liampas","year":"2024","journal-title":"Int. Psychogeriatr."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e70008","DOI":"10.1002\/gps.70008","article-title":"Neuropsychiatric Symptoms Associated With Frontotemporal Atrophy in Older Adults Without Dementia","volume":"39","author":"Liampas","year":"2024","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_73","first-page":"e70068","article-title":"Blood phosphorylated Tau181 reliably differentiates amyloid-positive from amyloid-negative subjects in the Alzheimer\u2019s disease continuum: A systematic review and meta-analysis","volume":"17","author":"Antonioni","year":"2025","journal-title":"Alzheimers Dement."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/15\/3\/241\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:42:02Z","timestamp":1760028122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/15\/3\/241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":74,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["brainsci15030241"],"URL":"https:\/\/doi.org\/10.3390\/brainsci15030241","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]}}}